Uric acid Reduction Ameliorates Transition to End-stage renal disease Study (URATE Study)

Authors
Category Primary study
JournalUMIN Clinical Trials Registry
Year 2008
INTERVENTION: administration of benzbromarone unadministration of benzbromarone CONDITION: hyperuricemia chronic kidney disease (CKD) PRIMARY OUTCOME: Death; Doubling of serum creatinine; Dialysis INCLUSION CRITERIA: ‐serum creatinine level ≥ 2.2mg/dl(male), ≥ 1.7mg/dl(female) serum urate level ≥ 7mg/dl ‐without acute alteration in renal function ‐stabilized patient under treatment within the CKD clinical practice guideline (by Japanese Society of Nephrology)
Epistemonikos ID: 952a65c9b78d7fb4d27a666a52f527faceb55bf6
First added on: Aug 21, 2024